Pancreatic cancer trials in Chile

3 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

  Where

  Santiago

  Age

  12 years and over

  People

  355 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT04924075 · EU 2023-504853-11-00
• Phase 1/2Taking people
  A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

  Where

  Providencia, Santiago, Temuco

  Age

  18 years and over

  People

  220 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06428409 · EU 2023-508703-21-00
• Phase 1/2Taking people
  A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  Where

  Concepción, La Serena, Santiago, Temuco

  Age

  18 years and over

  People

  680 worldwide

  Run by

  Daiichi Sankyo

  See details and how to joinNCT06330064 · EU 2023-509632-26-00